ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

331
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
09 Sep 2020 12:18

The Stocks to Own in Asia – Vol. 30

We highlight 14 stocks in Asia that look interesting to us based upon our FVMR Methodology. Our research team constantly reviews the Asia markets...

Share
05 Sep 2020 06:00

Asia Short Interest Weekly: Tencent, SMIC, Meituan, Galaxy, Kao, Sumitomo, Alteogen, Genius, Largan

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
352 Views
Share
bullishLG Chem Ltd
04 Sep 2020 12:20

Korea-New Deal Index: Constituents, Weights, & Market Reaction

The Korean government unveiled the specifics of the Korean version of the New Deal initiative.

Logo
330 Views
Share
bullishCelltrion Inc
04 Sep 2020 04:55

How Might a Celltrion Merger Look?

The key seems what happens to the value of Celltrion Holdings and in fact, the merger might not include Celltrion Inc.   The consensus belief is...

Logo
337 Views
Share
bullishWuxi Biologics
01 Sep 2020 18:25

Wuxi Biologics Placement - Another One Before Lock-Up, but Just in Time for the Index Inclusion

Wuxi Biologics (Cayman) Inc (2269 HK) has seen a total of ten placements since listing in Jun 2017. We've covered all of the deals. Given that the...

Logo
423 Views
Share
x